Nicardipine, a calcium channel blocking blood pressure lowering drug has shown anti prostate cancer properties in preclinical studies
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models
Xin Li, Yanhua Chen, Lijuan Bai, Rui Zhao, Yifei Wu, Zhong-Ru Xie, Jason M. Wu, Nathan J. Bowen, Alira Danaher, Nicholas Cook, Dehong Li, Min Qui, Yuhong Du, Haian
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models
Xin Li, Yanhua Chen, Lijuan Bai, Rui Zhao, Yifei Wu, Zhong-Ru Xie, Jason M. Wu, Nathan J. Bowen, Alira Danaher, Nicholas Cook, Dehong Li, Min Qui, Yuhong Du, Haian